Atlas Trials

Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).

Clinical trial NCT07622446 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07622446
Sponsor
Shanghai Dynaheart Medtech Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
High-risk PCI
Start date
2024-12-30
Primary completion
2026-02-09
Enrollment
254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.